What Does Semaglutide Look Like? Wegovy Injection Pen and Tablet, Described

Step 1 — recognise the Wegovy injection pen

The Wegovy injection pen is a pre-filled, disposable device made by Novo Nordisk. It is roughly the size and shape of a large highlighter pen, with a cap at one end covering the needle tip. The body is predominantly white or off-white, with a clear inspection window that lets you see the solution inside. That solution should be transparent and colourless, think water, not milky or tinted. The pen is dose-specific: each strength (0.25 mg through to 2.4 mg) is colour-coded on the label and cap, so the 0.25 mg starter pen looks visually different from the 1.7 mg or 2.4 mg maintenance pens. A quick habit worth building: before every injection, hold the pen up to a light source and look through the inspection window. If the liquid looks cloudy, has visible particles floating in it, or has changed colour, do not use that pen. Contact your pharmacy instead.

The pen delivers one dose per use, you press the button, hear a click, and the dose is complete. It is not a multi-dose vial. Injection sites are the abdomen, thigh or upper arm, rotated each week. For the precise storage and handling steps, the NHS semaglutide medicine page summarises what the patient information leaflet covers in full.

Step 2, recognise the newer 7.2 mg single-dose pen

On 14 April 2026 the MHRA approved a dedicated 7.2 mg single-dose Wegovy pen, and it looks noticeably different from the earlier format. The pen auto-doses (there is no dial or dose-selection window) and the needle is pre-set, covered, and locks permanently after a single use. In practice this means the pen feels more enclosed than the lower-dose versions: the tip area is shielded before, during and after injection. The cap and label carry 7.2 mg markings. If you have been titrating up through the standard schedule and receive this pen for the first time, the difference in feel and appearance can be surprising. It is the same medicine, delivered by a device designed specifically for this higher dose.

One important point about the 7.2 mg approval: it is licensed for BMI 30 or above only, and titration still starts at 0.25 mg, the higher pen is reached at the end of a prescriber-guided schedule, not at the beginning. If you are curious about what treatment at different stages looks and feels like day to day, the experience of being on Wegovy is covered in more detail separately.

Step 3, recognise the Wegovy tablet

The oral Wegovy tablet, approved by the MHRA on 11 June 2026, looks nothing like the injection pen. It is a small, film-coated oral tablet taken once daily. The tablet is co-formulated with an absorption enhancer called SNAC that allows semaglutide to cross the stomach lining. Because it requires no refrigeration, it looks and travels like most other daily oral medicines, compact, dry, kept at room temperature in its blister pack or bottle.

The dosing schedule runs from 1.5 mg up to a 25 mg maintenance dose, stepped through 4 mg and 9 mg with at least a month at each level. Those strengths bear no resemblance to the Rybelsus tablet, which is a different semaglutide product licensed for type 2 diabetes at 3 mg, 7 mg and 14 mg, a common point of confusion. If a pharmacist or peer mentions "oral semaglutide" without specifying the brand, it is worth clarifying which one they mean. The Wegovy overview page sets out both formats and what distinguishes them.

How the tablet is taken matters as much as what it looks like: first thing in the morning, on a completely empty stomach, with a small amount of plain water (up to around 120 ml). Food, coffee or other medicines should wait at least 30 minutes. If you use the Nexplanon implant for contraception, it is also worth reading about how Wegovy may interact with Nexplanon before starting treatment. The specific handling instructions are in the patient information leaflet; the MHRA products site carries the approved SmPC for exact detail.

How visual appearance connects to safety

For a prescription medicine, what it looks like is a genuine safety check, not just curiosity. The MHRA has documented counterfeit weight-loss pens entering the UK through unregulated online sellers, some contained substances other than the medicine on the label. Knowing what a genuine Wegovy pen looks like (clear colourless solution, branded pen body, correct dose labelling, refrigeration requirement) makes it easier to spot something that does not match. If the pen arrived at room temperature in unbranded packaging from an unverified source, or the solution looks cloudy, those are reasons to stop and verify.

Every pen dispensed through a GPhC-registered pharmacy should arrive via the licensed UK supply chain and come with a full patient information leaflet. You can verify any online pharmacy on the GPhC register before placing an order. If anything about the appearance of your medicine gives you pause, contacting your dispensing pharmacy is always the right first step, not a forum or a search engine.

Questions about whether Wegovy is right for you, and which format suits your circumstances, are exactly what a clinical consultation is for. People sometimes ask about the smell of semaglutide as another sensory check, and that is covered separately. The semaglutide information page gives a fuller clinical picture, and if cost is a factor, Wegovy pricing in the UK explains what private treatment typically involves.

If you are considering starting treatment, check your eligibility with our prescribers, the consultation is free, and the same clinician who reviews your answers makes the prescribing decision.